148 related articles for article (PubMed ID: 17505923)
21. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
[TBL] [Abstract][Full Text] [Related]
22. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
[TBL] [Abstract][Full Text] [Related]
23. Quality of life and its correlates in HIV/AIDS male outpatients receiving highly active antiretroviral therapy in Taiwan.
Yen CF; Tsai JJ; Lu PL; Chen YH; Chen TC; Chen PP; Chen TP
Psychiatry Clin Neurosci; 2004 Oct; 58(5):501-6. PubMed ID: 15482581
[TBL] [Abstract][Full Text] [Related]
24. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
25. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
[TBL] [Abstract][Full Text] [Related]
26. Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model.
Chu H; Gange SJ; Yamashita TE; Hoover DR; Chmiel JS; Margolick JB; Jacobson LP
Am J Epidemiol; 2005 Oct; 162(8):787-97. PubMed ID: 16135508
[TBL] [Abstract][Full Text] [Related]
27. Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda.
Mast TC; Kigozi G; Wabwire-Mangen F; Black R; Sewankambo N; Serwadda D; Gray R; Wawer M; Wu AW
AIDS Care; 2004 Jan; 16(1):81-94. PubMed ID: 14660146
[TBL] [Abstract][Full Text] [Related]
28. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
29. Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda.
Kipp W; Alibhai A; Saunders LD; Senthilselvan A; Kaler A; Konde-Lule J; Okech-Ojony J; Rubaale T
AIDS Care; 2010 Mar; 22(3):271-8. PubMed ID: 20390506
[TBL] [Abstract][Full Text] [Related]
30. Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.
Toulson AR; Harrigan R; Heath K; Yip B; Brumme ZL; Harris M; Hogg RS; Montaner JS
J Infect Dis; 2005 Nov; 192(10):1787-93. PubMed ID: 16235178
[TBL] [Abstract][Full Text] [Related]
31. The societal burden of HIV/AIDS in Northern Italy: an analysis of costs and quality of life.
Hubben GA; Bishai D; Pechlivanoglou P; Cattelan AM; Grisetti R; Facchin C; Compostella FA; Bos JM; Postma MJ; Tramarin A
AIDS Care; 2008 Apr; 20(4):449-55. PubMed ID: 18449822
[TBL] [Abstract][Full Text] [Related]
32. Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study.
Dragsted UB; Mocroft A; Vella S; Viard JP; Hansen AB; Panos G; Mercey D; Machala L; Horban A; Lundgren JD;
J Infect Dis; 2004 Jul; 190(1):148-55. PubMed ID: 15195254
[TBL] [Abstract][Full Text] [Related]
33. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment.
Préau M; Leport C; Salmon-Ceron D; Carrieri P; Portier H; Chene G; Spire B; Choutet P; Raffi F; Morin M
AIDS Care; 2004 Jul; 16(5):649-61. PubMed ID: 15223534
[TBL] [Abstract][Full Text] [Related]
35. Impact on weight and height with the use of HAART in HIV-infected children.
Guillén S; Ramos JT; Resino R; Bellón JM; Muñoz MA
Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
[TBL] [Abstract][Full Text] [Related]
36. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
[TBL] [Abstract][Full Text] [Related]
37. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
38. Time perspective and quality of life among HIV-infected patients in the context of HAART.
Préau M; Apostolidis T; Francois C; Raffi F; Spire B
AIDS Care; 2007 Apr; 19(4):449-58. PubMed ID: 17453582
[TBL] [Abstract][Full Text] [Related]
39. Relationship between CD4 count and quality of life over time among HIV patients in Uganda: a cohort study.
Mwesigire DM; Martin F; Seeley J; Katamba A
Health Qual Life Outcomes; 2015 Sep; 13():144. PubMed ID: 26370702
[TBL] [Abstract][Full Text] [Related]
40. Depressive and Anxiety Symptoms Predict Sustained Quality of Life Deficits in HIV-Positive Ugandan Adults Despite Antiretroviral Therapy: A Prospective Cohort Study.
Ezeamama AE; Woolfork MN; Guwatudde D; Bagenda D; Manabe YC; Fawzi WW; Smith Fawzi MC
Medicine (Baltimore); 2016 Mar; 95(9):e2525. PubMed ID: 26945347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
